- Home
- AUTL vs OLP Comparison
AUTL vs OLP Comparison
Compare AUTL & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- OLP
- Stock Information
- Founded
- AUTL 2014
- OLP 1982
- Country
- AUTL United Kingdom
- OLP United States
- Employees
- AUTL N/A
- OLP N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- OLP Real Estate Investment Trusts
- Sector
- AUTL Health Care
- OLP Real Estate
- Exchange
- AUTL Nasdaq
- OLP Nasdaq
- Market Cap
- AUTL 590.8M
- OLP N/A
- IPO Year
- AUTL 2018
- OLP N/A
- Fundamental
- Price
- AUTL $2.17
- OLP $25.92
- Analyst Decision
- AUTL Strong Buy
- OLP Strong Buy
- Analyst Count
- AUTL 3
- OLP 1
- Target Price
- AUTL $10.20
- OLP $28.00
- AVG Volume (30 Days)
- AUTL 1.1M
- OLP 46.6K
- Earning Date
- AUTL 03-13-2025
- OLP 03-04-2025
- Dividend Yield
- AUTL N/A
- OLP 7.06%
- EPS Growth
- AUTL N/A
- OLP 51.11
- EPS
- AUTL N/A
- OLP 1.63
- Revenue
- AUTL $10,091,000.00
- OLP $89,142,000.00
- Revenue This Year
- AUTL $851.83
- OLP N/A
- Revenue Next Year
- AUTL $224.65
- OLP $4.71
- P/E Ratio
- AUTL N/A
- OLP $15.65
- Revenue Growth
- AUTL 82.71
- OLP N/A
- 52 Week Low
- AUTL $2.07
- OLP $19.75
- 52 Week High
- AUTL $7.37
- OLP $30.45
- Technical
- Relative Strength Index (RSI)
- AUTL 41.40
- OLP 45.92
- Support Level
- AUTL $2.07
- OLP $25.27
- Resistance Level
- AUTL $2.26
- OLP $25.93
- Average True Range (ATR)
- AUTL 0.12
- OLP 0.50
- MACD
- AUTL 0.01
- OLP 0.12
- Stochastic Oscillator
- AUTL 25.00
- OLP 71.79
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.